Earnings Call · Q2 FY2026·2026-08-12

Q2 26EPS -80.00%·Rev n/aQ1 26EPS +61.54%·Rev n/aQ4 25EPS -100.00%·Rev n/aQ3 25EPS -7.69%·Rev n/a⚠ consensus missing

Aquestive Therapeutics, Inc. AQST

Faith Pomeroy Ward — Investor Relations

Dan Barber — President and Chief Executive Officer

Ernie Toth — Chief Financial Officer

−4.1%1d on move date3d−3.6%5d−2.0%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more AQST calls or request research access.

More AQST calls Browse calls Request research access